Apolipoprotein E genotype and its pathological correlation in Chinese Alzheimer's disease with late onset.

[1]  John X. Morris.  Diagnosis of Alzheimer’s Disease , 2019, Alzheimer’s Disease.

[2]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[3]  D. Mash,et al.  Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. , 1998, Journal of neuropathology and experimental neurology.

[4]  C. M. Lum,et al.  Prevalence of dementia in Chinese elderly in Hong Kong , 1998, Neurology.

[5]  J. Price,et al.  Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. , 1998, Archives of neurology.

[6]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[7]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[8]  R. Tanzi,et al.  Molecular Mechanisms of Dementia , 1997, Nature Medicine.

[9]  T. Lehtimäki,et al.  Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains , 1997, Neurobiology of Aging.

[10]  A D Roses,et al.  Apolipoprotein E-epsilon 2 and Alzheimer's disease , 1997, Neurology.

[11]  W. Poon,et al.  Alzheimer-type of pathological changes in Chinese , 1997, Journal of the Neurological Sciences.

[12]  K. Blennow,et al.  The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[13]  M. Pericak-Vance,et al.  Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease , 1996, The Lancet.

[14]  M. Yamada,et al.  Apolipoprotein E and the neuropathology of dementia. , 1996, The New England journal of medicine.

[15]  E. Hui,et al.  Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese , 1996, Neurology.

[16]  B T Hyman,et al.  Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease , 1996, Annals of neurology.

[17]  K Kontula,et al.  Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. , 1995, The New England journal of medicine.

[18]  A. Hofman,et al.  The apolipoprotein E ε2 allele is associated with an increased risk of early‐onset alzheimer's disease and a reduced survival , 1995 .

[19]  S. Gauthier,et al.  Predictive value of apolipoprotein E genotyping in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies , 1994, Annals of neurology.

[20]  S. Sorbi,et al.  ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease , 1994, Neuroscience Letters.

[21]  A. Roses,et al.  Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. , 1994, The Journal of clinical investigation.

[22]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[23]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Mirra,et al.  Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. , 1993, Archives of pathology & laboratory medicine.

[26]  A. Hofman,et al.  Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980–1990 prevalence findings , 1991, Annals of neurology.

[27]  E. Boerwinkle,et al.  The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. , 1991, American journal of human genetics.

[28]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[29]  A. Syvänen,et al.  Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction: convenient alternative to phenotyping by isoelectric focusing. , 1990, Clinical chemistry.

[30]  D. Salmon,et al.  The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education , 1990, Annals of neurology.

[31]  M. Albert,et al.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.

[32]  J. C. Lee,et al.  Degenerative cerebral alterations in Chinese aged 65 years or older. , 1988, Clinical neuropathology.

[33]  H. Ng.  Alzheimer's disease and Alzheimer-type of cerebral degenerations in Chinese. , 1994, Clinical and experimental neurology.

[34]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[35]  L. Heimer.  The Human Brain and Spinal Cord , 1983, Springer US.